SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-05-000962
Filing Date
2005-10-26
Accepted
2005-10-26 15:04:07
Documents
2
Group Members
THIRD POINT LLCTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 l3032581b.txt SC 13D/A 14616
3 LETTER TO SHAREHOLDERS l3032581c.txt EX-1 5962
  Complete submission text file 0000899140-05-000962.txt   22497
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43329 | Film No.: 051156835
SIC: 2834 Pharmaceutical Preparations

Mailing Address THIRD POINT MANAGEMENT COMPANY L.L.C. 360 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017
Business Address (212) 224-7400
Loeb Daniel S (Filed by) CIK: 0001300345 (see all company filings)

Type: SC 13D/A